このページの翻訳は実験的なもので、現在開発中です。お待ちしております！

Maxnerva Technology Services 将来の成長

Future 基準チェック /06

現在、 Maxnerva Technology Servicesの成長と収益を予測するのに十分なアナリストの調査がありません。

主要情報

n/a

収益成長率

n/a

EPS成長率

IT 収益成長	12.1%
収益成長率	n/a
将来の株主資本利益率	n/a
アナリストカバレッジ	None
最終更新日	n/a

今後の成長に関する最新情報

Recent updates

Maxnerva Technology Services Limited (HKG:1037) Surges 33% Yet Its Low P/S Is No Reason For Excitement

Apr 10

Maxnerva Technology Services Limited's (HKG:1037) Share Price Boosted 29% But Its Business Prospects Need A Lift Too

Feb 21

Maxnerva Technology Services Limited's (HKG:1037) Share Price Is Matching Sentiment Around Its Earnings

Dec 30

Here's What's Concerning About Maxnerva Technology Services' (HKG:1037) Returns On Capital

Oct 12

There Are Reasons To Feel Uneasy About Maxnerva Technology Services' (HKG:1037) Returns On Capital

Jun 29

Maxnerva Technology Services' (HKG:1037) Returns On Capital Not Reflecting Well On The Business

Dec 26

Maxnerva Technology Services (HKG:1037) Is Reinvesting At Lower Rates Of Return

Sep 27

Maxnerva Technology Services' (HKG:1037) Returns On Capital Are Heading Higher

Mar 18

Maxnerva Technology Services (HKG:1037) Is Experiencing Growth In Returns On Capital

Dec 03

Maxnerva Technology Services (HKG:1037) Shareholders Will Want The ROCE Trajectory To Continue

Jul 26

Calculating The Intrinsic Value Of Maxnerva Technology Services Limited (HKG:1037)

May 11

Returns Are Gaining Momentum At Maxnerva Technology Services (HKG:1037)

Apr 06

How Much Did Maxnerva Technology Services'(HKG:1037) Shareholders Earn From Share Price Movements Over The Last Five Years?

Mar 02

Here's Why Maxnerva Technology Services' (HKG:1037) Statutory Earnings Are Arguably Too Conservative

Feb 04

Maxnerva Technology Services Limited's (HKG:1037) Stock On An Uptrend: Could Fundamentals Be Driving The Momentum?

Jan 14

Is There More Growth In Store For Maxnerva Technology Services' (HKG:1037) Returns On Capital?

Dec 16

このセクションでは通常、投資家が会社の利益創出能力を理解する一助となるよう、プロのアナリストのコンセンサス予想に基づく収益と利益の成長予測を提示する。しかし、Maxnerva Technology Services は十分な過去のデータを提供しておらず、アナリストの予測もないため、過去のデータを外挿したり、アナリストの予測を使用しても、その将来の収益を確実に算出することはできません。

シンプリー・ウォール・ストリートがカバーする企業の97%は過去の財務データを持っているため、これはかなり稀な状況です。

業績と収益の成長予測

SEHK:1037 - アナリストの将来予測と過去の財務データ ( )CNY Millions
日付	収益	収益	フリー・キャッシュフロー	営業活動によるキャッシュ	平均アナリスト数
12/31/2023	678	-17	31	33	N/A
9/30/2023	753	5	20	21	N/A
6/30/2023	827	27	9	10	N/A
3/31/2023	830	28	14	16	N/A
12/31/2022	832	28	20	22	N/A
9/30/2022	765	28	23	26	N/A
6/30/2022	697	29	25	29	N/A
3/31/2022	647	32	18	22	N/A
12/31/2021	596	34	11	15	N/A
9/30/2021	560	25	-10	-10	N/A
6/30/2021	524	16	-31	-35	N/A
3/31/2021	524	16	10	9	N/A
12/31/2020	523	15	51	53	N/A
9/30/2020	530	15	N/A	N/A	N/A
6/30/2020	536	15	87	97	N/A
3/31/2020	483	13	81	89	N/A
12/31/2019	431	12	75	81	N/A
9/30/2019	402	20	N/A	N/A	N/A
6/30/2019	374	28	6	12	N/A
3/31/2019	350	14	-11	-6	N/A
12/31/2018	326	1	-27	-24	N/A
12/31/2017	447	57	-33	-29	N/A
9/30/2017	328	79	N/A	48	N/A
6/30/2017	334	85	N/A	44	N/A
3/31/2017	345	92	N/A	40	N/A
12/31/2016	361	22	N/A	N/A	N/A
9/30/2016	262	-23	N/A	-29	N/A
6/30/2016	178	-43	N/A	-39	N/A
3/31/2016	93	-61	N/A	-47	N/A
12/31/2015	93	-29	N/A	N/A	N/A
9/30/2015	92	3	N/A	-26	N/A
6/30/2015	97	3	N/A	-32	N/A
3/31/2015	104	3	N/A	-38	N/A
9/30/2014	292	4	N/A	-23	N/A
6/30/2014	396	4	N/A	-11	N/A
3/31/2014	496	4	N/A	2	N/A
9/30/2013	457	-1	N/A	-127	N/A
6/30/2013	446	5	N/A	-93	N/A

アナリストによる今後の成長予測

収入対貯蓄率: 1037の予測収益成長が貯蓄率 ( 2.2% ) を上回っているかどうかを判断するにはデータが不十分です。

収益対市場: 1037の収益がHong Kong市場よりも速く成長すると予測されるかどうかを判断するにはデータが不十分です

高成長収益: 1037の収益が今後 3 年間で大幅に増加すると予想されるかどうかを判断するにはデータが不十分です。

収益対市場: 1037の収益がHong Kong市場よりも速く成長すると予測されるかどうかを判断するにはデータが不十分です。

高い収益成長: 1037の収益が年間20%よりも速く成長すると予測されるかどうかを判断するにはデータが不十分です。

一株当たり利益成長率予想

将来の株主資本利益率

将来のROE: 1037の自己資本利益率が 3 年後に高くなると予測されるかどうかを判断するにはデータが不十分です

Maxnerva Technology Services 将来の成長

Future 基準チェック /06

主要情報

今後の成長に関する最新情報

Maxnerva Technology Services Limited Provides Earnings Guidance for the Six Months Ended 30 June 2022

Recent updates

Now 21% undervalued

Maxnerva Technology Services Limited, Annual General Meeting, May 24, 2024

New major risk - Share price stability

Now 27% undervalued

Maxnerva Technology Services Limited (HKG:1037) Surges 33% Yet Its Low P/S Is No Reason For Excitement

Full year 2023 earnings released: CN¥0.024 loss per share (vs CN¥0.04 profit in FY 2022)

Maxnerva Technology Services Limited Announces Chief Executive Officer Changes

Maxnerva Technology Services Limited to Report Fiscal Year 2023 Results on Mar 26, 2024

Maxnerva Technology Services Limited's (HKG:1037) Share Price Boosted 29% But Its Business Prospects Need A Lift Too

Maxnerva Technology Services Limited's (HKG:1037) Share Price Is Matching Sentiment Around Its Earnings

Here's What's Concerning About Maxnerva Technology Services' (HKG:1037) Returns On Capital

Maxnerva Technology Services Limited Announces Board Changes

First half 2023 earnings released: EPS: CN¥0.008 (vs CN¥0.009 in 1H 2022)

Maxnerva Technology Services Limited to Report First Half, 2023 Results on Aug 28, 2023

There Are Reasons To Feel Uneasy About Maxnerva Technology Services' (HKG:1037) Returns On Capital

Full year 2022 earnings released: EPS: CN¥0.04 (vs CN¥0.05 in FY 2021)

Maxnerva Technology Services' (HKG:1037) Returns On Capital Not Reflecting Well On The Business

Less than half of directors are independent

First half 2022 earnings released: EPS: CN¥0.009 (vs CN¥0.017 in 1H 2021)

Maxnerva Technology Services (HKG:1037) Is Reinvesting At Lower Rates Of Return

First half 2022 earnings released: EPS: CN¥0.009 (vs CN¥0.017 in 1H 2021)

Maxnerva Technology Services Limited Provides Earnings Guidance for the Six Months Ended 30 June 2022

Maxnerva Technology Services Limited to Report Q2, 2022 Results on Aug 26, 2022

Less than half of directors are independent

Full year 2021 earnings released: EPS: CN¥0.05 (vs CN¥0.022 in FY 2020)

Maxnerva Technology Services' (HKG:1037) Returns On Capital Are Heading Higher

Maxnerva Technology Services (HKG:1037) Is Experiencing Growth In Returns On Capital

First half 2021 earnings released: EPS CN¥0.017 (vs CN¥0.015 in 1H 2020)

First half 2021 earnings released: EPS CN¥0.017 (vs CN¥0.015 in 1H 2020)

Maxnerva Technology Services (HKG:1037) Shareholders Will Want The ROCE Trajectory To Continue

Calculating The Intrinsic Value Of Maxnerva Technology Services Limited (HKG:1037)

Non-Executive Director has left the company

Returns Are Gaining Momentum At Maxnerva Technology Services (HKG:1037)

Full year 2020 earnings released: EPS CN¥0.022 (vs CN¥0.018 in FY 2019)

Maxnerva Technology Services Limited to Report Fiscal Year 2020 Results on Mar 31, 2021

How Much Did Maxnerva Technology Services'(HKG:1037) Shareholders Earn From Share Price Movements Over The Last Five Years?

New 90-day high: HK$0.90

Here's Why Maxnerva Technology Services' (HKG:1037) Statutory Earnings Are Arguably Too Conservative

Maxnerva Technology Services Limited's (HKG:1037) Stock On An Uptrend: Could Fundamentals Be Driving The Momentum?

New 90-day high: HK$0.65

Is There More Growth In Store For Maxnerva Technology Services' (HKG:1037) Returns On Capital?

New 90-day high: HK$0.47

First half earnings released

New 90-day high - HK$0.34

Earnings released

業績と収益の成長予測

アナリストによる今後の成長予測

一株当たり利益成長率予想

将来の株主資本利益率

成長企業の発掘